Attorneys from Heim, Payne & Chorush Score Two More Victories for Arigna Technology in Latest Patent Battles
WASHINGTON, D.C. – Led by name partner Michael Heim, the Houston-based intellectual property boutique Heim, Payne & Chorush, LLP, has prevailed again on behalf of Ireland’s Arigna Technology Limited after winning consecutive favorable decisions from the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board in Washington, D.C.
Mr. Heim and Heim, Payne & Chorush associate Chris Limbacher scored the latest victories for Arigna based on challenges to its patents by the corporate-funded patent litigation group Unified Patents, LLC, and technology giant Apple Inc. Read coverage of the win in The Texas Lawbook here.
Mr. Heim and Mr. Limbacher scored the first recent win with a PTAB judgment issued on June 13 in Unified Patents, LLC v. Arigna Technology Ltd., IPR2022-00285. The final written decision issued by the PTAB followed Unified Patents’ attempt to invalidate a claim tied to Arigna’s U.S. Patent No. 7,049,850 B2, which covers technology widely used in the automotive industry. The 12-page ruling found that Unified Patents failed to establish its claim beyond a preponderance of the evidence.
The following day, a different three-judge PTAB panel ruled in favor of Arigna following Apple’s request for an inter partes review of Arigna’s U.S. Patent No. 7,183,835 B2. Apple’s attempt to contest two claims covering a semiconductor technology patent was denied in a 46-page decision in Apple Inc. v. Arigna Technology Ltd., IPR2023-00453. The panel’s ruling represents a complete victory for Arigna.
Heim, Payne & Chorush has scored multiple wins before the PTAB on behalf of Arigna, including victories last year against Volkswagen Group of America and BMW of North America ahead of a blockbuster December ruling denying a challenge to an essential Arigna patent filed by Apple, LG Electronics, Inc., and Samsung Electronics Co., Ltd. Earlier this year, the firm won another PTAB decision against BMW of North America when a three-judge panel denied the company’s attempt to invalidate 32 different claims tied to an Arigna patent used widely in the automotive industry.